AI-Assisted Analysis of Clinical Trials to Identify Failed Drugs for Revival via Drug Delivery Technologies
An OpenAI-based framework was developed to systemically analyze terminated trials on ClinicalTrials.gov and may provide a new direction to apply AI technologies for drug development, and inspire future investigations of clinical reports and public information from the perspective of delivery technology applications.